Gaglia, Michael A <br/><br/>
Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.  [electronic resource] 

 -  Cardiovascular revascularization medicine : including molecular interventions   
 - 76-80 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-0938 
<br/><br/><label>Standard No.: </label>10.1016/j.carrev.2012.12.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aspirin--adverse effects<br/>Biomarkers--blood<br/>Blood Platelets--drug effects<br/>Cell Adhesion Molecules--blood<br/>Chi-Square Distribution<br/>Clopidogrel<br/>Cross-Sectional Studies<br/>Drug Therapy, Combination<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Microfilament Proteins--blood<br/>Middle Aged<br/>Percutaneous Coronary Intervention--adverse effects<br/>Phosphoproteins--blood<br/>Piperazines--adverse effects<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Platelet Function Tests<br/>Prasugrel Hydrochloride<br/>Predictive Value of Tests<br/>Purinergic P2Y Receptor Antagonists--adverse effects<br/>Receptors, Purinergic P2Y12--blood<br/>Risk Factors<br/>Severity of Illness Index<br/>Thiophenes--adverse effects<br/>Ticlopidine--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Vasodilator-Stimulated Phosphoprotein